|
|
|
Volumn 23, Issue 4, 1996, Pages 494-505
|
|
Endocrine therapies of breast cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOGLUTETHIMIDE;
ANASTROZOLE;
ANDROGEN;
ANTIANDROGEN;
ANTIESTROGEN;
ANTIGESTAGEN;
AROMATASE INHIBITOR;
BUSERELIN;
CYPROTERONE;
DIETHYLSTILBESTROL;
DROLOXIFENE;
ESTROGEN;
EXEMESTANE;
FADROZOLE;
FLUOXYMESTERONE;
FLUTAMIDE;
FORMESTANE;
FULVESTRANT;
GESTAGEN;
GONADORELIN DERIVATIVE;
GOSERELIN;
IDOXIFENE;
LETROZOLE;
LEUPRORELIN;
MEDROXYPROGESTERONE ACETATE;
MEGESTROL ACETATE;
MIFEPRISTONE;
PYRIDOGLUTETHIMIDE;
TAMOXIFEN;
TOREMIFENE;
VOROZOLE;
ADRENALECTOMY;
BREAST CANCER;
CANCER HORMONE THERAPY;
CLINICAL TRIAL;
DRUG MECHANISM;
DRUG RESISTANCE;
HUMAN;
HYPOPHYSECTOMY;
OVARIECTOMY;
PRIORITY JOURNAL;
REVIEW;
AMINOGLUTETHIMIDE;
ANDROGENS;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
ENDOCRINE GLANDS;
ENZYME INHIBITORS;
ESTROGEN ANTAGONISTS;
ESTROGENS;
FEMALE;
HORMONE ANTAGONISTS;
HUMANS;
PROGESTINS;
TAMOXIFEN;
|
|
EID: 0029794922
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (48)
|
|
References (0)
|
